PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Morso London is a modern community-centred restaurant that serves hand-crafted freshly made pasta and Italian bites with grappa-based cocktails. Launched in June 2018, the restaurant is created by a team of industry veterans. Paolo Vernetti is the Co-founder, head chef and CEO of Morso. Since Dec 2018, Morso has been TripAdvisor's Top 50 restaurant. The restaurant has received more than 100 5 star reviews. Morso was covered by Fay Maschler’s “Week in Food”, The Upcoming, The Infatuation and many other important food/media publications. Morso has achieved a 3x weekly sales growth from June 2018 to Jan 2019. It is achieving a positive site EBITDA on the 6th month of trading. Morso is planning to grow by opening two more sites in 2019.
days to go:
Expired
investment:
£99,950
Yumbles is a leading UK online marketplace for artisan food. It currently connects over 600 independent food makers directly with consumers. The company is targeting the UK’s estimated £10bn+ UK Speciality Food & Drink market, having seen £1m+ sales in the last 12 months resulting in £400k+ revenue.
days to go:
Expired
investment:
£262,080
Hawkens Gingerbread is a bakery that makes gingerbread products that are diverse, rich in heritage, delicious, and high in quality. It has spent three years in a start-up phase and now targets a three-year phase of stage one growth. Currently, its facility can bake up to 80,000 units of gingerbread each month. Since 2017, it is consistently producing a 65% average gross profit margin across its B2C and B2B markets. This company has been growing for three years, and in the financial year 2019, its revenue grew 108% to £43k (£25k profit). Its online sales are displaying a strong flow in the upwards direction. Fund raised will enable it to get in front of a much wider audience and bring the necessary skills into the business.
days to go:
Expired
investment:
£67,110
Winebuyers connect vineyards and wine merchants directly to the end consumer revolutionising a traditional industry. They make their revenue by charging the suppliers a monthly fee and have had 2,700 companies registering their interest to be involved in the platform. The funding will go towards strengthening their infrastructure, extending their marketing activities and to growing the business quickly and efficiently.
(SEIS Partial)
days to go:
Expired
investment:
£568,870
Wantsum Brewery are a brewery based in East Kent with the aim to create more 'hoppy' beers. Wantsum Brewery currently produce 8 regular ales and 10 seasonal and special ales which are sold to pubs and bottle outlets throughout East Kent.
days to go:
Expired
investment:
£40,150
Vegums develop multivitamin gummies for a vegan and plant-based lifestyle. The company argues that some vitamins are difficult to get from a plant-only diet, such as vitamin D, B12, and iodine. Vegums has researched and incorporated non-animal vitamin ingredients into its products to address that issue. The company asserts that its products are 100% plastic-free and biodegradable. It claims that the number of vegans in the UK grew by 40% in 2020, and shows no sign of slowing down in 2021. It aims to become a contender in this segment. Vegums won the World Plant Award 2020 for the 'Best Plant-Based Start-Up', has a social media following of over 15,700 on Instagram, achieved 4.8/5 on TrustPilot, and scaled from selling 1 pack of Vegums to over 9,000 a month to its customers. It will use the investment for New Product Development (NPD), team expansion, and launching into new markets and countries.
days to go:
Expired
investment:
£312,463
